Cognitive decline caused by reduced blood flow to the brain, often following a stroke or reflecting cumulative damage from small vessel disease.
Medically reviewed by
Dr. Mihaela G.
Neurocognitive Disorder due to Vascular Disease describes cognitive decline resulting from reduced or interrupted blood flow to the brain, whether from a single significant stroke, a series of smaller strokes that individually went unnoticed, or cumulative damage from chronic small vessel disease affecting blood vessels deep within the brain. This is the second most common cause of major cognitive decline in older adults, after Alzheimer’s disease, and the two conditions frequently overlap, sharing risk factors and, in many people, occurring together as a mixed presentation rather than as entirely separate, mutually exclusive processes.
A genuinely distinctive feature of vascular NCD, compared to the typically smooth, gradual decline of Alzheimer’s disease, is its potential for a stepwise, sometimes more abrupt course, particularly when caused by a series of distinct strokes; cognitive function can remain relatively stable for a period, then drop noticeably following a new vascular event, rather than declining at a steady, continuous pace. That said, vascular NCD from chronic small vessel disease alone can also present with a more gradual decline, making the specific pattern genuinely variable depending on the underlying vascular process involved.
What makes this condition particularly important to understand is that, unlike Alzheimer’s disease, vascular risk factors are directly modifiable; addressing blood pressure, diabetes, cholesterol, and other cardiovascular risk factors doesn’t just support general health, it directly addresses the underlying mechanism causing this specific type of cognitive decline, making prevention and risk reduction genuinely actionable in a way that’s somewhat different from Alzheimer’s disease.
Onset connected to a vascular event
Cognitive decline that develops in close temporal relationship to a stroke, or shows clear evidence of decline that’s prominent in attention and executive function (planning, organizing, decision-making) consistent with vascular disease.
Prominent executive dysfunction
Compared to Alzheimer’s disease, vascular NCD often shows more prominent impairment in executive function and processing speed relatively early on, sometimes with memory comparatively better preserved than in typical Alzheimer’s presentations, at least initially.
Stepwise or fluctuating course
Particularly with multiple distinct strokes, decline can occur in a stepwise pattern, periods of stability followed by a noticeable drop after a new vascular event, rather than smooth, continuous decline.
Physical neurological signs
Depending on the location and extent of vascular damage, physical signs such as weakness, gait disturbance, or other neurological findings consistent with the underlying vascular disease may be present alongside the cognitive changes.
Mild versus Major presentation
As with other causes, Mild Neurocognitive Disorder due to Vascular Disease involves noticeable decline that doesn’t yet significantly impair independence, while Major Neurocognitive Disorder involves decline severe enough to require assistance with everyday activities.
⋅ Depression, particularly common and sometimes pronounced following stroke
⋅ Apathy and reduced emotional engagement
⋅ Irritability or emotional lability, sometimes connected to specific areas of brain damage
⋅ Anxiety connected to awareness of cognitive changes or fear of further vascular events
⋅ Impaired planning, organizing, and decision-making, often prominent relatively early
⋅ Slowed processing speed
⋅ Memory difficulty, though sometimes comparatively less prominent early on than in Alzheimer’s disease
⋅ Difficulty with attention and sustained focus on tasks
⋅ Physical weakness or other neurological signs, depending on the specific vascular damage
⋅ Gait disturbance or balance difficulty
⋅ Symptoms connected to the underlying vascular event itself, such as residual stroke effects
⋅ Increased fall risk connected to both cognitive and physical changes
⋅ Sudden or stepwise changes in functioning following a new vascular event
⋅ Withdrawal from activities, particularly connected to apathy or depression
⋅ Increasing difficulty managing complex tasks like finances, especially as decline progresses
⋅ Behavior changes consistent with the specific brain regions affected by vascular damage
Vascular NCD accounts for roughly 15-20% of major neurocognitive disorder cases, making it the second most common identifiable cause after Alzheimer’s disease, with mixed Alzheimer’s-vascular presentations increasingly recognized as common rather than rare.
Risk factors include all major cardiovascular risk factors: high blood pressure, diabetes, high cholesterol, smoking, obesity, and atrial fibrillation, alongside a personal history of stroke or transient ischemic attack (“mini-stroke”). These overlap substantially with risk factors for heart disease and stroke more broadly, reflecting the shared underlying vascular mechanism.
Comorbidity with depression is particularly notable and significant following stroke specifically, and comorbidity with Alzheimer’s disease pathology is common enough that many cases reflect a genuinely mixed presentation rather than purely vascular or purely Alzheimer’s-related decline.
Vascular NCD results directly from damage to brain tissue caused by interrupted or reduced blood flow, through several possible mechanisms.
Large strokes causing significant, identifiable damage to brain regions important for cognition can produce a relatively sudden, sometimes dramatic decline, with the specific cognitive effects depending considerably on which brain regions were affected.
Multiple smaller strokes, sometimes called “silent strokes” because they may not produce obvious, immediately recognized symptoms at the time they occur, can accumulate over time, with their cumulative effect eventually producing noticeable cognitive decline, often in the characteristic stepwise pattern.
Small vessel disease, chronic damage to the brain’s smallest blood vessels, often connected to long-term high blood pressure, produces more diffuse, gradual damage, sometimes presenting with a more continuous rather than stepwise decline pattern.
Shared risk factors with cardiovascular disease directly explain why the same factors damaging blood vessels throughout the body, high blood pressure, diabetes, high cholesterol, smoking, also damage the brain’s blood supply specifically, directly causing this type of cognitive decline rather than simply correlating with it incidentally.
Mild and Major Neurocognitive Disorder due to Vascular Disease are diagnosed using the same general framework as other neurocognitive disorder etiologies, modest or significant cognitive decline respectively, but require evidence specifically pointing to a vascular cause: either clear temporal relationship between cognitive decline and one or more documented cerebrovascular events, or evidence of decline that’s prominent in complex attention and executive function, consistent with vascular disease, alongside evidence from history, physical examination, or neuroimaging of cerebrovascular disease judged sufficient to account for the cognitive deficits.
Differential diagnosis requires distinguishing this from Alzheimer’s disease, which more typically shows prominent early memory impairment with a smoother decline pattern, though, importantly, mixed presentations involving both conditions are common and should be actively considered rather than assuming a single, exclusive cause. Brain imaging plays a particularly important role in this specific diagnosis, helping identify and characterize the vascular damage directly contributing to the clinical picture.
Treatment for Vascular NCD centers on preventing further vascular damage, alongside supportive measures similar to those used for other neurocognitive disorders.
Aggressive management of cardiovascular risk factors
This is the most important treatment principle specific to this condition; carefully controlling blood pressure, blood sugar, and cholesterol, alongside smoking cessation where relevant, directly addresses the mechanism causing ongoing damage and can help prevent further decline, distinguishing this disorder’s treatment approach somewhat from Alzheimer’s disease.
Antiplatelet or anticoagulant medication
Depending on the specific underlying cause, medications to reduce stroke risk, such as antiplatelet agents or anticoagulants, may be appropriate, generally determined in coordination with neurology.
Cholinesterase inhibitors
While not specifically approved for vascular NCD, these medications, primarily developed for Alzheimer’s disease, are sometimes used given the frequent overlap between the two conditions and some evidence of modest benefit.
Addressing depression directly
Given how common and significant post-stroke depression specifically can be, direct treatment of this comorbid condition is an important component of comprehensive care.
Rehabilitation and supportive care
Physical, occupational, and speech therapy, where relevant given any physical neurological effects, alongside structured routines and caregiver support, support functioning and quality of life throughout the course of the condition.
Take blood pressure, diabetes, and cholesterol management seriously if you’ve been told you have vascular cognitive decline. Unlike some other causes of cognitive decline, this is a condition where actively managing these specific health factors can directly help slow or prevent further progression.
Don’t smoke, and seek support to quit if you currently do. This is one of the most directly modifiable risk factors connected to this specific type of cognitive decline.
Watch for sudden changes in thinking or function, and seek prompt medical attention if they occur. Given the stepwise pattern sometimes seen with this condition, a sudden change could indicate a new vascular event requiring urgent evaluation.
Address any depression directly, especially if it developed after a stroke. This is extremely common and very treatable, and addressing it can meaningfully improve overall quality of life and engagement with other aspects of care.
Stay connected with both neurology and primary care for coordinated, comprehensive management. Given how directly cardiovascular health connects to this condition, ongoing coordination between specialists matters considerably.
The outlook for Vascular NCD is genuinely variable and depends considerably on the specific underlying cause and how effectively ongoing vascular risk factors are managed going forward.
Unlike Alzheimer’s disease, where progression is largely expected regardless of intervention, vascular NCD’s course can be meaningfully influenced by aggressive management of cardiovascular risk factors, potentially slowing or even halting further decline by preventing additional vascular events.
The stepwise pattern, when present, means periods of relative stability are genuinely possible between vascular events, though each new event carries risk of further decline, underscoring why prevention efforts matter so significantly for this particular condition.
Mixed presentations involving both vascular and Alzheimer’s pathology tend to follow a course influenced by both underlying processes, and comprehensive management addressing both is generally the most effective approach when this overlap is present.
Seek immediate emergency care for any sudden change in thinking, speech, vision, or physical function, since this could represent an acute stroke requiring urgent treatment.
Seek evaluation if you notice gradual cognitive decline alongside known cardiovascular risk factors or a history of stroke, given how important accurate diagnosis is for appropriate treatment planning.
Seek aggressive management of blood pressure, diabetes, and cholesterol if you’ve been diagnosed with this condition, given how directly this can influence the future course.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
Vascular dementia is cognitive decline caused by reduced or interrupted blood flow to the brain, whether from a major stroke, several smaller strokes, or long-term damage to small blood vessels deep in the brain. It’s the second most common cause of dementia after Alzheimer’s disease, and the two conditions often overlap in the same person.
Yes, to a meaningful degree, this is one of the more hopeful aspects of this particular diagnosis. Because it’s caused by vascular damage, aggressively managing blood pressure, blood sugar, and cholesterol, along with quitting smoking, can directly help prevent further vascular events and may slow or even stop additional decline. This is different from Alzheimer’s disease, where the underlying disease process is harder to directly influence.
This varies a lot depending on the cause. If it’s connected to several distinct strokes, decline can happen in a stepwise way, periods where things stay the same, followed by a sudden drop after a new stroke. If it’s caused by gradual small vessel damage instead, the decline tends to be slower and more continuous. This is different from the typically smoother, steady decline often seen in Alzheimer’s disease.
Vascular dementia is caused by interrupted blood flow to the brain, often connected to strokes or long-term blood vessel damage, while Alzheimer’s is caused by specific protein buildup in the brain. Vascular dementia often affects planning and decision-making earlier, while memory may be relatively better preserved at first, the opposite of the typical early pattern in Alzheimer’s. Many people actually have both conditions together, which is called a mixed presentation.
Iadecola, C., Duering, M., Hachinski, V., Joutel, A., Pendlebury, S. T., Schneider, J. A., & Dichgans, M. (2019). Vascular cognitive impairment and dementia. Journal of the American College of Cardiology, 73(25), 3326–3344. PubMed
Skrobot, O. A., O’Brien, J., Black, S., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., Pantoni, L., Pasquier, F., Roman, G. C., Wallin, A., Sachdev, P., Skoog, I., Taragano, F. E., Kazee, A. M., Köhler, S., O’Brien, J. T., Sachdev, P. S., … Kehoe, P. G. (2016). The vascular impairment of cognition classification consensus study. Alzheimer’s & Dementia, 13(6), 624–633. PubMed
Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., … Seshadri, S. (2011). Vascular contributions to cognitive impairment and dementia. Stroke, 42(9), 2672–2713. PubMed
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., Vinters, H. V., Zlokovic, B. V., Seshadri, S., Schindler, B., & Leblanc, G. G. (2006). National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke, 37(9), 2220–2241. PubMed
O’Brien, J. T., & Thomas, A. (2015). Vascular dementia. The Lancet, 386(10004), 1698–1706. PubMed
